We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

30 hedge funds and large institutions have $3.27M invested in Microbot Medical in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

0.79% more ownership

Funds ownership: 13.97% → 14.76% (+0.79%)

0% more funds holding

Funds holding: 30 → 30 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

30% less capital invested

Capital invested by funds: $4.66M → $3.27M (-$1.39M)

Holders
30
Holders Change
–
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$71.8K
2
BlackRock
BlackRock
New York
+$65.6K
3
JP Morgan Chase
JP Morgan Chase
New York
+$60K
4
SPIA
Steward Partners Investment Advisory
New York
+$19.9K
5
Morgan Stanley
Morgan Stanley
New York
+$18.2K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$23K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.32K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$132
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$7
5
Wells Fargo
Wells Fargo
California
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.06M +$71.8K +10,838 +6%
BlackRock
2
BlackRock
New York
$945K +$65.6K +9,906 +6%
SM
3
Sabby Management
Florida
$429K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$238K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$214K – – –
Bank of New York Mellon
6
Bank of New York Mellon
New York
$136K +$13 +2 +0%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$68K – – –
Millennium Management
8
Millennium Management
New York
$67K -$23K -3,467 -21%
JP Morgan Chase
9
JP Morgan Chase
New York
$45K +$60K +9,068 New
Morgan Stanley
10
Morgan Stanley
New York
$32K +$18.2K +2,748 +77%
SPIA
11
Steward Partners Investment Advisory
New York
$15K +$19.9K +3,000 New
UBS Group
12
UBS Group
Switzerland
$12K +$14.1K +2,128 +1,509%
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$3K -$132 -20 -3%
Wells Fargo
14
Wells Fargo
California
$1K -$7 -1 -0.5%
Deutsche Bank
15
Deutsche Bank
Germany
$1K +$1.58K +238 +238%
FDCDDQ
16
Federation des caisses Desjardins du Quebec
Quebec, Canada
$21 – – –
RE
17
RBC Europe
United Kingdom
$5 – – –
Fidelity Investments
18
Fidelity Investments
Massachusetts
– -$1.32K -199 -100%
Bank of Montreal
19
Bank of Montreal
Ontario, Canada
– -$7 -1 -33%
Bank of America
20
Bank of America
North Carolina
– +$7 +1 +25%
JPLA
21
Joseph P. Lucia & Associates
New York
– +$7 +1 New
RWA
22
Redhawk Wealth Advisors
Minnesota
– +$7 +1 New

MBOT Hedge Fund Activity: Q2 2019 in Review

30 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2019, worth a combined $3.27M — down 30% from $4.66M a quarter earlier.

Fund positioning in MBOT was balanced in Q2 2019: 4 funds opened new positions, 4 closed out, 7 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $71.8K. The largest seller was Millennium Management, cutting an estimated $23K.

  • 30 institutional investors held Microbot Medical (MBOT) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $3.27M of Microbot Medical stock for Q2 2019, down 30% quarter-over-quarter.
  • 4 funds opened new Microbot Medical positions in Q2 2019 and 4 closed out, a net change of 0 holders.
  • The largest Microbot Medical buyer in Q2 2019 was Renaissance Technologies, an estimated $71.8K added.
  • The largest Microbot Medical seller in Q2 2019 was Millennium Management, an estimated $23K sold.

Based on aggregated 13F filings for Q2 2019.